Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

NCT02082522 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Accrual rate remaining too low

Conditions

Hilar Cholangiocarcinoma

Interventions

DRUG: Photodynamic therapy-Photofrin
PROCEDURE: Stenting procedure
DRUG: Chemotherapy regimen

Sponsor

Concordia Laboratories Inc.